| Echocardiographic examination |  | |
---|---|---|---|
 | Yes (n= 80) | No (n= 194) |  |
 | n (%) | P * | |
Sociodemographic characteristics | |||
   Male | 26 (33) | 50 (26) | 0.28 |
   Institutionalized | 17 (21) | 87 (45) | <0.001 |
   Education ≤ 6 years primary school | 38 (48) | 132 (68) | 0.002 |
   Income ≤ 750€ | 34 (43) | 105 (54) | 0.09 |
Functional characteristics | |||
   Cognitive impairment (MMSE ≤ 18) | 0 (0) | 72 (38) | <0.001 |
   Poor well-being (CANTRIL < 7) | 16 (20) | 35 (29) | 0.14 |
   Dependent in daily living (GARS ≥ 56) | 4 (5) | 64 (34) | <0.001 |
   Depression (GDS-15 ≥ 5) | 11 (14) | 37 (31) | 0.003 |
Clinical characteristics | |||
   Cardiovascular morbidity | 48 (60) | 132 (68) | 0.22 |
Specific cardiac diagnosesa | 47 (59) | 120 (62) | 0.63 |
Atrial fibrillation on ECG | 8 (10.0) | 25 (13) | 0.49 |
Diagnosis of heart failure | 20 (25) | 39 (21) | 0.43 |
Other vascular morbidityb | 11 (14) | 33 (18) | 0.45 |
Cardiovascular risk factors | Â | Â | Â |
Hypertension | 47 (59) | 104 (55) | 0.58 |
Diabetes mellitus type II | 10 (13) | 35 (21) | 0.12 |
   Non-cardiovascular morbidityc | 49 (61) | 126 (65) | 0.56 |
BMI > 25 kg/m2 | 50 (65) | 101 (64) | 0.88 |
GFR < 60 mL/min/1.73 m2 | 43 (54) | 100 (52) | 0.74 |
Anemiad | 11 (15) | 51 (28) | 0.014 |
Cardiovascular medicatione | 34 (43) | 97 (50) | 0.26 |
NT-proBNP in pg/mL (median, IQR) | 389.5 (220.7-779.1) | 471.9 (252.8-1655.3) | 0.10‡ |